Vaxcyte, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 45
Rang # Quantité totale PI 30 912
Note d'activité PI 2,5/5.0    45
Rang # Activité PI 16 410
Symbole boursier
ISIN US92243G1085
Capitalisation 11,600M  (USD)
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

13 6
8 4
9 4
1
 
Dernier brevet 2024 - Conjugated vaccine carrier proteins
Premier brevet 2017 - Polypeptide-antigen conjugates w...
Dernière marque 2024 - VAXCYTE PROTECT HUMANKIND
Première marque 2019 - VAXCYTE

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Human vaccine preparations; human vaccines; vaccines namely prophylactic and therapeutic vaccines...
Invention Polypeptide-antigen conjugates with non-natural amino acids. Methods for the production of immun...
Invention Purification of capsular polysaccharides. S. pneumoniae S. pneumoniae serotype capsular polysacch...
Invention Aerotolerant bacteria fermentation. Described herein are processes for the fermentation of aeroto...
Invention Stabilization of adjuvanted vaccine compositions and their use. The present disclosure provides ...
Invention Conjugated vaccine carrier proteins. Methods for the production of immunogenic compositions cont...
2023 Invention Purification processes for polysaccharides and polypeptide conjugates thereof. The present discl...
P/S Vaccines; therapeutic vaccines; vaccine preparations. Research and development of vaccines and me...
Invention Periodontitis vaccine and related compositions and methods of use. Porphyromonas bacterium.
Invention Enterococcus faecalis vaccine and uses thereof. EnterococcusE. faecalis, E. faeciumE. duransEnter...
Invention Carrier-protein polysaccharide conjugation methods. The present disclosure provides methods of p...
2022 P/S Vaccines; vaccine preparations; therapeutic vaccines. Research and development of vaccines and me...
Invention Stabilization of adjuvanted vaccine compositions and their use. The present disclosure provides s...
Invention Group a strep immunogenic compositions with polysaccharide-protein conjugates. The present discl...
Invention Animal product-free culture of streptococcus bacteria. The present disclosure provides methods, ...
P/S Research and development of vaccines and medicines
P/S Vaccines; Vaccine preparations; Therapeutic vaccines
Invention Purification processes for polysaccharides and polypeptide conjugates thereof. The present disclo...
P/S Vaccines; Therapeutic vaccines; Vaccine preparations Research and development of vaccines and med...
2021 Invention Optimized cell-free synthesis of invasion plasmid antigen b and related compositions and methods ...
Invention Carrier-protein polysaccharide conjugation methods. The present disclosure provides methods of pr...
Invention Group a strep immunogenic compositions with polysaccharide-protein conjugates. The present disclo...
2020 Invention Animal product-free culture of streptococcus bacteria. The present disclosure provides methods, c...
Invention Animal product-free culture of streptococcus bacteria. in vitroin vitro cultivation of catalase-n...
P/S Protein carrier for use in pharmaceutical preparation.
P/S Protein carrier for use in pharmaceutical preparation.
P/S Human vaccines; human vaccine preparations; therapeutic human vaccines. Research and development ...
2019 P/S protein carrier for use in pharmaceutical preparation
P/S Vaccines; vaccine preparations; therapeutic vaccines
Invention Conjugated vaccine carrier proteins. Methods for the production of immunogenic compositions conta...
Invention Improvements in immunogenic conjugates. The present application discloses various improvements co...
2018 Invention Periodontitis vaccine and related compositions and method of use. An immunogenic composition, a p...
2017 Invention Polypeptide-antigen conjugates with non-natural amino acids. Methods for the production of immuno...